Lung cancer is one of the leading causes of cancer-related deaths worldwide. Early detection through screening can significantly improve survival rates. Lung-RADS provides a systematic approach to interpret and report LDCT findings, which helps in the early detection of lung cancer. By reducing false positives and negatives, Lung-RADS ensures that patients receive appropriate follow-up care, thus improving outcomes.
